Zymeworks
ZYME
157 hedge funds and large institutions have $724M invested in Zymeworks in 2023 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 54 increasing their positions, 39 reducing their positions, and 14 closing their positions.
136% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 14
135% more call options, than puts
Call options by funds: $1.4M | Put options by funds: $596K
83% more capital invested
Capital invested by funds: $396M → $724M (+$329M)
38% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 39
13% more funds holding
Funds holding: 139 → 157 (+18)
7.72% more ownership
Funds ownership: 91.89% → 99.61% (+7.7%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$41.7M |
| 2 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$6.57M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$6.17M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$3.41M |
| 5 |
BlackRock
New York
|
+$2.43M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$2.96M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$1.94M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.87M |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$1.66M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$1.48M |
ZYME Hedge Fund Activity: Q4 2023 in Review
157 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Zymeworks (ZYME) for Q4 2023, worth a combined $724M — up 83% from $396M a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new ZYME positions and 14 closed out — a net gain of 19 holders — while 54 added to existing stakes and 39 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $41.7M. The largest seller was Perceptive Advisors, cutting an estimated $2.96M.
- 157 institutional investors held Zymeworks (ZYME) as of Q4 2023, up from 139 in Q3 2023.
- Funds reported $724M of Zymeworks stock for Q4 2023, up 83% quarter-over-quarter.
- 33 funds opened new Zymeworks positions in Q4 2023 and 14 closed out, a net change of +19 holders.
- The largest Zymeworks buyer in Q4 2023 was Morgan Stanley, an estimated $41.7M added.
- The largest Zymeworks seller in Q4 2023 was Perceptive Advisors, an estimated $2.96M sold.
Based on aggregated 13F filings for Q4 2023.